Inhaled nitric oxide (iNO) has now been used clinically since 1991, or twelve years. The acute aims of therapy have mainly been improvement of oxygenation and reduction of lung vasoconstriction. This is true also for the use in ALI (acute lung injury) of various degrees of severity including ARDS (acute respiratory distress syndrome).